Next Generation Sequencing Market Set to Skyrocket: Projected to Reach $97.8 Billion by 2035 at 18.3% CAGR

June 18, 2025 02:14 AM AEST | By EIN Presswire
 Next Generation Sequencing Market Set to Skyrocket: Projected to Reach $97.8 Billion by 2035 at 18.3% CAGR
Image source: EIN Presswire

The global next generation sequencing market is projected to reach $97.8 billion by 2035, growing at a CAGR of 18.3% from 2024 to 2035. PORTLAND, OR, UNITED STATES, June 17, 2025 /EINPresswire.com/ -- The Next Generation Sequencing (NGS) market is experiencing significant growth in 2025, driven by advancements in genomic research and increasing applications in personalized medicine. Key factors contributing to this growth include the declining costs of sequencing technologies, which have made genomic analysis more accessible, and the rising demand for NGS in clinical diagnostics, particularly in oncology and rare disease detection. The global next generation sequencing market was valued at $13 billion in 2023, and is projected to reach $97.8 billion by 2035, growing at a CAGR of 18.3% from 2024 to 2035.

👉 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝗟𝗮𝘁𝗲𝘀𝘁 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/request-sample/2048

NGS has many advantages over traditional sequencing methods, such as Sanger sequencing. NGS is faster, more accurate, and more cost-effective, making it possible to analyze entire genomes or transcriptomes in a single run. Additionally, NGS can detect genetic variations, such as single nucleotide polymorphisms (SNPs) and structural variations, that may be missed by other methods.

Major market players covered in the report, such as -

• Agilent Technologies, Inc.,
• ILLUMINA INC.,
• PRECIGEN INC,
• Qiagen N.V,
• abgi group,
• F. HOFFMANN-LA ROCHE AG,
• Thermo Fisher Scientific Inc. ,
• PerkinElmer, Inc,
• Pacific Biosciences of California

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟮𝟳𝟱 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @
https://www.alliedmarketresearch.com/next-generation-sequencing-market/purchase-options

Key Benefits for Stakeholders -

• The report provides quantitative analysis of market segments, current trends, strategies and potential of Next Generation Sequencing Market research to identify potential Next Generation Sequencing Market opportunities in genetics.
• In-depth analysis of this sector helps identify current market opportunities.
• Market analysis and information related to key drivers, restraints and opportunities are provided. • Porter's Five Forces Analysis identifies the capabilities of buyers and suppliers to enable stakeholders to make profitable business decisions and strengthen the network of buyers.
• The largest countries in each region are listed according to their contribution to the global market.
• Focusing on market players makes benchmarking easier and provides a clear understanding of the current market situation.
• The report includes regional and global Next Generation Sequencing Market analysis, key players, market segments, application areas and Market growth strategies.

NGS has numerous applications in research, clinical diagnostics, and personalized medicine. In research, NGS can be used to study genetic diseases, identify biomarkers, and study the microbiome. In clinical diagnostics, NGS can be used to diagnose genetic disorders, detect cancer mutations, and monitor treatment response. In personalized medicine, NGS can be used to tailor treatments to an individual's genetic makeup, improving efficacy and reducing side effects.

NGS has also enabled the emergence of new fields, such as metagenomics and epigenomics. Metagenomics allows for the study of entire microbial communities, providing insights into microbial diversity and function. Epigenomics allows for the study of changes in gene expression, which can have important implications for disease development and progression.

In conclusion, NGS has revolutionized the field of genomics, providing a powerful tool for the analysis of genetic material. The speed, accuracy, and cost-effectiveness of NGS have opened up new possibilities in research, clinical diagnostics, and personalized medicine, paving the way for a more comprehensive understanding of genetic diseases and new approaches to treatment.

♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐄𝐧𝐪𝐮𝐢𝐫𝐲 -
https://www.alliedmarketresearch.com/purchase-enquiry/2048

Frequently Asked Questions?

Q1. Which is base year calculated in the next generation sequencing market market report?

Q2. Which are the top companies hold the market share in next generation sequencing market market?

Q3. Which is the most influencing segment growing in the next generation sequencing market market report?

Q4. What are the key trends in the next generation sequencing market market report?

Q5. What are next generation sequencing market?

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Market Research
+ + 1800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.